会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • METHOD FOR PREVENTION OF AGE-RELATED MACULAR DEGENERATION (AMD)
    • 预防年龄相关性变性的方法(AMD)
    • WO2008110283A2
    • 2008-09-18
    • PCT/EP2008/001688
    • 2008-03-04
    • DSM IP ASSETS B.V.BENDIK, IgorSANCAK, ÖzgürSCHALCH, WolfgangWITTWER, Jonas
    • BENDIK, IgorSANCAK, ÖzgürSCHALCH, WolfgangWITTWER, Jonas
    • C12Q1/6886C12Q2600/172
    • A method of prevention of age-related macular degeneration (AMD) involves, in a first step, taking a sample from an individual and detecting the presence of a polymorphism (rsl 1200638 or rs 10490924, or an SNP related to or associated with a (high temperature requirement) serine protease). In a second step the individual is provided with a substance that can prevent AMD, or can mitigate or alleviate symptoms of AMD. The substance is a medication comprising lutein and/or zeaxanthin and/or certain antioxidants (or a mixture thereof) is tailored to that individual. The invention also provides a method of determining the substance to be administered to an individual, which individual may be susceptible of having age-related macular degeneration (or an age-related macular degeneration-related disorder) by detecting the presence of the polymorphism and identifying a substance capable of preventing or treating age-related macular degeneration in that individual. The method may additionally comprise providing (such as administering or communicating) the substance (or its identity) to the individual.
    • 预防年龄相关性黄斑变性(AMD)的方法涉及在第一步中从个体取样并检测多形性(rs1200638或rs10490924,或与(或 高温要求)丝氨酸蛋白酶)。 在第二步中,个体被提供可以预防AMD的物质,或者可以减轻或缓解AMD的症状。 该物质是包含叶黄素和/或玉米黄质的药物和/或某些抗氧化剂(或其混合物)适合于该个体。 本发明还提供了一种确定要给予个体的物质的方法,该个体可能通过检测多态性的存在并鉴定其可能具有年龄相关性黄斑变性(或年龄相关性黄斑变性相关病症) 能够预防或治疗该个体年龄相关性黄斑变性的物质。 该方法可以另外包括向个体提供(例如管理或通信)物质(或其身份)。
    • 2. 发明申请
    • METHOD FOR PREVENTION OF AGE-RELATED MACULAR DEGENERATION (AMD)
    • 预防与年龄相关的黄斑变性(AMD)的方法
    • WO2008110828A1
    • 2008-09-18
    • PCT/GB2008/000925
    • 2008-03-14
    • DSM IP ASSETS B.V.WRIGHT, Simon, MarkBENDIK, IgorSANCAK, ÖzgürSCHALCH, WolfgangWITTWER, Jonas
    • BENDIK, IgorSANCAK, ÖzgürSCHALCH, WolfgangWITTWER, Jonas
    • C12Q1/68
    • C12Q1/6883C12Q2600/136C12Q2600/172
    • A method of prevention of age-related macular degeneration (AMD) involves, in a first step, taking a sample from an individual and detecting the presence of a polymorphism (rsl 1200638 or rs 10490924, or an SNP related to or associated with a (high temperature requirement) serine protease). In a second step the individual is provided with a substance that can prevent AMD, or can mitigate or alleviate symptoms of AMD. The substance is a medication comprising lutein and/or zeaxanthin and/or certain antioxidants (or a mixture thereof) is tailored to that individual. The invention also provides a method of determining the substance to be administered to an individual, which individual may be susceptible of having age-related macular degeneration (or an age-related macular degeneration-related disorder) by detecting the presence of the polymorphism and identifying a substance capable of preventing or treating age-related macular degeneration in that individual. The method may additionally comprise providing (such as administering or communicating) the substance (or its identity) to the individual.
    • 预防年龄相关性黄斑变性(AMD)的方法包括,在第一步中,从个体取样品并检测多态性(rs1112638或rs10490924或 与(高温需求)丝氨酸蛋白酶相关或相关的SNP)。 在第二步中,向个体提供能够预防AMD的物质,或者可以缓解或缓解AMD的症状。 该物质是含有叶黄素和/或玉米黄质和/或某种抗氧化剂(或其混合物)的个体的药物。 本发明还提供了测定待施用于个体的物质的方法,所述个体可能通过检测多态性的存在并鉴定出与年龄相关的黄斑变性(或与年龄相关的黄斑变性有关的病症) 能够预防或治疗该个体的年龄相关性黄斑变性的物质。 该方法可以另外包括向个体提供(例如给予或传递)物质(或其身份)。